- Lobbying
- Lobbying by Biogen, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Brian Pomper | Ch Intl Trade Cnsl, Intl Trade Cnsl, Senate Fin |
Josh Teitelbaum | Deputy Assistant Secretary of Commerce, 2014-2016; Staff Director, US Senate HELP Subcommittee on Children and Families, 2013-2014; Legislative Assistant, Senator Kay Hagan, 2011-2013; Legislative Counsel, Congressman Steve Israel, 2009-2011 |
Heide Bajnrauh | Sen McCain LSA, 96-97 |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to healthcare drug pricing, Medicare Part B, Biosimilars, therapeutic issues, and intellectual property..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate